BACKGROUND: This study aimed to determine the knowledge, attitudes and practices of Swiss business travelers with regard to malaria. METHODS: Questionnaires printed in three languages were distributed by employers, travel agencies and tropical medicine specialists to business travelers with destinations in malaria endemic countries. RESULTS: In total, 401 questionnaires were evaluated. Thirty-three percent visited high-risk areas, 27% visited low-risk areas, and 40% visited only malaria-free areas within endemic countries. Among the investigated business travelers, 6% had experienced malaria infection, and 29% had previously had blood smears tested for malaria at least once. Almost all business travelers, 95%, knew that mosquitoes are the main vectors of malaria. The infection risk between dusk and dawn was known to 71%, and the incubation time to 36%. Apart from fever (99%) and headache (63%), other malaria symptoms were known to only 13% to 36% of the travelers. If signs of illness such as fever and headache occurred, 63% would react adequately and seek medical advice within 24 h. Only 16% of the travelers to African high-risk areas followed the recommended behavior concerning anti-mosquito and antimalarial strategies; 31% of those on trips to low-risk areas used an adequate protective strategy. Of the business travelers using chemoprophylaxis during travel, just 50% continued intake post travel, as requested, after leaving the endemic area. CONCLUSIONS: Business travelers are well informed regarding the mode of transmission and the risk of malaria at specific destinations but tend to comply poorly with anti-mosquito and chemoprophylactic strategies. The knowledge, attitudes and practices of business travelers with regard to malaria prevention need to be improved.
BACKGROUND: This study aimed to determine the knowledge, attitudes and practices of Swiss business travelers with regard to malaria. METHODS: Questionnaires printed in three languages were distributed by employers, travel agencies and tropical medicine specialists to business travelers with destinations in malaria endemic countries. RESULTS: In total, 401 questionnaires were evaluated. Thirty-three percent visited high-risk areas, 27% visited low-risk areas, and 40% visited only malaria-free areas within endemic countries. Among the investigated business travelers, 6% had experienced malaria infection, and 29% had previously had blood smears tested for malaria at least once. Almost all business travelers, 95%, knew that mosquitoes are the main vectors of malaria. The infection risk between dusk and dawn was known to 71%, and the incubation time to 36%. Apart from fever (99%) and headache (63%), other malaria symptoms were known to only 13% to 36% of the travelers. If signs of illness such as fever and headache occurred, 63% would react adequately and seek medical advice within 24 h. Only 16% of the travelers to African high-risk areas followed the recommended behavior concerning anti-mosquito and antimalarial strategies; 31% of those on trips to low-risk areas used an adequate protective strategy. Of the business travelers using chemoprophylaxis during travel, just 50% continued intake post travel, as requested, after leaving the endemic area. CONCLUSIONS: Business travelers are well informed regarding the mode of transmission and the risk of malaria at specific destinations but tend to comply poorly with anti-mosquito and chemoprophylactic strategies. The knowledge, attitudes and practices of business travelers with regard to malaria prevention need to be improved.
Authors: Jorge A Falcón-Lezama; Ruth A Martínez-Vega; Pablo A Kuri-Morales; José Ramos-Castañeda; Ben Adams Journal: Bull Math Biol Date: 2016-10-04 Impact factor: 1.758
Authors: Lin H Chen; Karin Leder; Kira A Barbre; Patricia Schlagenhauf; Michael Libman; Jay Keystone; Marc Mendelson; Philippe Gautret; Eli Schwartz; Marc Shaw; Sue MacDonald; Anne McCarthy; Bradley A Connor; Douglas H Esposito; Davidson Hamer; Mary E Wilson Journal: J Travel Med Date: 2018-01-01 Impact factor: 8.490
Authors: Poh-Lian Lim; Pauline Han; Lin H Chen; Susan MacDonald; Prativa Pandey; DeVon Hale; Patricia Schlagenhauf; Louis Loutan; Annelies Wilder-Smith; Xiaohong M Davis; David O Freedman Journal: BMC Infect Dis Date: 2012-12-31 Impact factor: 3.090
Authors: Nomana M Khan; Emily S Jentes; Clive Brown; Pauline Han; Sowmya R Rao; Phyllis Kozarsky; Stefan H F Hagmann; Regina C LaRocque; Edward T Ryan Journal: J Occup Environ Med Date: 2016-01 Impact factor: 2.162
Authors: Lin H Chen; Mary E Wilson; Xiaohong Davis; Louis Loutan; Eli Schwartz; Jay Keystone; Devon Hale; Poh Lian Lim; Anne McCarthy; Effrossyni Gkrania-Klotsas; Patricia Schlagenhauf Journal: Emerg Infect Dis Date: 2009-11 Impact factor: 6.883
Authors: Amy Pinsent; Jonathan M Read; Jamie T Griffin; Valerie Smith; Peter W Gething; Azra C Ghani; Geoffrey Pasvol; T Déirdre Hollingsworth Journal: Malar J Date: 2014-08-04 Impact factor: 2.979